ProfileGDS5678 / 1433190_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 67% 67% 67% 66% 66% 70% 66% 67% 66% 69% 67% 66% 66% 67% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 14.082967
GSM967853U87-EV human glioblastoma xenograft - Control 24.0388967
GSM967854U87-EV human glioblastoma xenograft - Control 34.0432767
GSM967855U87-EV human glioblastoma xenograft - Control 43.9583866
GSM967856U87-EV human glioblastoma xenograft - Control 53.9857466
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 14.3109270
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 24.0763666
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 34.0353867
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 44.0210366
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 14.2219369
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 24.0309367
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.9832866
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.9935966
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 54.030467